Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms

Physiological Research

Volumn 60, Issue 1, 2011, Pages 139-148

  Wedellova Z ^a,b   Dietrich, J ^c   Siklova Vitkova M ^a   Kolostova K ^a   Kovacikova M ^a   Duskova M ^b   Broz J ^b   Vedral, T ^b   Stich V ^a,b   Polak J ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c TECHNICAL UNIVERSITY OF APPLIED SCIENCES WILDAU   (Germany)

Author keywords

Adiponectin; Adipose tissue; AMPK; Lipolysis; Obesity

Indexed keywords

EID: 79955816295     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.931863     Document Type: Article

References (58)

1. AGUADO M, MARTINEZ-URBISTONDO D, SOLOMON A, MARTINEZ JA Gender-dependent differences in the response of human adipocytes to leptin lipolytic action. Methods Find Exp Clin Pharmacol 30: 7-11, 2008.
2. ARNER P Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19: 471-482, 2005.
3. ARNER P, KRIEGHOLM E, ENGFELDT P, BOLINDER J Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest 85: 893-898, 1990.
4. BALDEWEG SE, GOLAY A, NATALI A, BALKAU B, DEL PRATO S, COPPACK SW Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest 30: 45-52, 2000.
5. BICKERTON AS, ROBERTS R, FIELDING BA, HODSON L, BLAAK EE, WAGENMAKERS AJ, GILBERT M, KARPE F, FRAYN KN Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176, 2007.
6. BODEN G Obesity and free fatty acids. Endocrinol Metab Clin North Am 37: 635-636, 2008.
7. BRUCE CR, MERTZ VA, HEIGENHAUSER GJ, DYCK DJ The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes. 54: 3154-3160, 2005.
8. CARMEN GY, VICTOR SM Signalling mechanisms regulating lipolysis. Cell Signal 18: 401-408, 2006.
9. CAWTHORN WP, SETHI JK TNF-alpha and adipocyte biology. FEBS Lett 582: 117-131, 2008.
10. CHEN MB, MCAINCH AJ, MACAULAY SL, CASTELLI LA, O'BRIEN PE, DIXON JB, CAMERON-SMITH D, KEMP BE, STEINBERG GR Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90: 3665-3672, 2005.
11. CHEN X, IQBAL N, BODEN G The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
12. CIVITARESE AE, JENKINSON CP, RICHARDSON D, BAJAJ M, CUSI K, KASHYAP S, BERRIA R, BELFORT R, DEFRONZO RA, MANDARINO LJ, RAVUSSIN E Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47: 816-820, 2004.
13. DAVAL M, FOUFELLE F, FERRE P Functions of AMP-activated protein kinase in adipose tissue. J Physiol 574: 55-62, 2006.
14. DEEPA SS, DONG LQ APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 296: E22-E36, 2009.
15. DIAZ-GUERRA MJ, JUNCO M, BOSCA L Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes. J Biol Chem 266: 23568-23576, 1991.
16. FASSHAUER M, KLEIN J, KRALISCH S, KLIER M, LOSSNER U, BLUHER M, PASCHKE R Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 558: 27-32, 2004.
17. FRAYN KN Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc 60: 375-380, 2001.
18. GAO Y, ZHOU Y, XU A, WU D Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull 31: 1716-1722, 2008.
19. GARTON AJ, CAMPBELL DG, CARLING D, HARDIE DG, COLBRAN RJ, YEAMAN SJ Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur J Biochem 179: 249-254, 1989.
20. GARTON AJ, YEAMAN SJ Identification and role of the basal phosphorylation site on hormone-sensitive lipase. Eur J Biochem 191: 245-250, 1990.
21. HALUZIK M, PARIZKOVA J, HALUZIK MM Adiponectin and its role in the obesity-induced insulin resistance and related complications. Minireview. Physiol Res 53: 123-129, 2004.
22. VAN HARMELEN V, LONNQVIST F, THORNE A, WENNLUND A, LARGE V, REYNISDOTTIR S, ARNER P Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes 21: 972-979, 1997.
23. HAYES C, KRISKA A Role of physical activity in diabetes management and prevention. J Am Diet Assoc 108: S19-S23, 2008.
24. HOFFSTEDT J, ARNER P, HELLERS G, LONNQVIST F Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 38: 795-804, 1997.
25. HOJLUND K, MUSTARD KJ, STAEHR P, HARDIE DG, BECK-NIELSEN H, RICHTER EA, WOJTASZEWSKI JF AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 286: E239-E244, 2004.
26. HOLM C Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31: 1120-1124, 2003.
27. JOCKEN JW, SMIT E, GOOSSENS GH, ESSERS YP, VAN BAAK MA, MENSINK M, SARIS WH, BLAAK EE Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific. Histochem Cell Biol 129: 535-538, 2008.
28. KADOWAKI T, YAMAUCHI T, KUBOTA N, HARA K, UEKI K, TOBE K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792, 2006.
29. KOH HJ, HIRSHMAN MF, HE H, LI Y, MANABE Y, BALSCHI JA, GOODYEAR LJ Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem J 403: 473-481, 2007.
30. KOLEHMAINEN M, OHISALO JJ, KAARTINEN JM, TUONONEN V, PAAKKONEN M, POIKOLAINEN E, ALHAVA E, UUSITUPA MI Concordance of in vivo microdialysis and in vitro techniques in the studies of adipose tissue metabolism. Int J Obes Relat Metab Disord 24: 1426-1432, 2000.
31. LAESSLE RG, WURMSER H, PIRKE KM A comparison of resting metabolic rate, self-rated food intake, growth hormone, and insulin levels in obese and nonobese preadolescents. Physiol Behav 61: 725-729, 1997.
32. LAFONTAN M, MORO C, BERLAN M, CRAMPES F, SENGENES C, GALITZKY J Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19: 130-137, 2008.
33. LANGIN D, DICKER A, TAVERNIER G, HOFFSTEDT J, MAIRAL A, RYDEN M, ARNER E, SICARD A, JENKINS CM, VIGUERIE N, VAN HERMELEN V, GROSS RW, HOLM C, ARNER P Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54: 3190-3197, 2005.
34. LARGE V, ARNER P Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24: 409-418, 1998.
35. LUNDGREN M, BUREN J, LINDGREN P, MYRNAS T, RUGE T, ERIKSSON JW Sex- and depot-specific lipolysis regulation in human adipocytes: interplay between adrenergic stimulation and glucocorticoids. Horm Metab Res 40: 854-860, 2008.
36. MAO X, KIKANI CK, RIOJAS RA, LANGLAIS P, WANG L, RAMOS FJ, FANG Q, CHRIST-ROBERTS CY, HONG JY, KIM RY, LIU F, DONG LQ APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523, 2006.
37. MAURIEGE P, IMBEAULT P, LANGIN D, LACAILLE M, ALMERAS N, TREMBLAY A, DESPRES JP Regional and gender variations in adipose tissue lipolysis in response to weight loss. J Lipid Res 40: 1559-1571, 1999.
38. MITSUUCHI Y, JOHNSON SW, SONODA G, TANNO S, GOLEMIS EA, TESTA JR Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoproteinserine/threonine kinase AKT2. Oncogene 18: 4891-4898, 1999.
39. MOLLER N, JORGENSEN JO Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine reviews 30: 152-177, 2009.
40. MULLEN KL, PRITCHARD J, RITCHIE I, SNOOK LA, CHABOWSKI A, BONEN A, WRIGHT D, DYCK DJ Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fatfed rats. Am J Physiol Regul Integr Comp Physiol 296: R243-R251, 2009.
41. NEDVIDKOVA J, SMITKA K, KOPSKY V, HAINER V Adiponectin, an adipocyte-derived protein. Minireview. Physiol Res 54: 133-140, 2005.
42. PAOLISSO G, GAMBARDELLA A, AMATO L, TORTORIELLO R, D'AMORE A, VARRICCHIO M, D'ONORFIO F Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38: 1295-1299, 1995.
43. POLAK J, MORO C, BESSIERE D, HEJNOVA J, MARQUES MA, BAJZOVA M, LAFONTAN M, CRAMPES F, BERLAN M, STICH V Acute exposure to long-chain fatty acids impairs α2-adrenergic receptor-mediated antilipolysis in human adipose tissue. J Lipid Res 48: 2236-2246, 2007.
44. QVISTH V, HAGSTROM-TOFT E, ENOKSSON S, MOBERG E, ARNER P, BOLINDER J Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J Clin Endocrinol Metab 91: 665-670, 2006.
45. RANDLE PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
46. RODBELL M Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375-380, 1964.
47. SAITO T, JONES CC, HUANG S, CZECH MP, PILCH PF The interaction of Akt with APPL1 is required for insulinstimulated Glut4 translocation. J Biol Chem 282: 32280-32287, 2007.
48. STAIGER H, KALTENBACH S, STAIGER K, STEFAN N, FRITSCHE A, GUIRGUIS A, PETERFI C, WEISSER M, MACHICAO F, STUMVOLL M, HARING HU Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 53: 2195-2201, 2004.
49. STEINBERG GR, SMITH AC, VAN DENDEREN BJ, CHEN Z, MURTHY S, CAMPBELL DJ, HEIGENHAUSER GJ, DYCK DJ, KEMP BE AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 89: 4575-4580, 2004.
50. STICH V, PELIKANOVA T, WOHL P, SENGENES C, ZAKAROFF-GIRARD A, LAFONTAN M, BERLAN M Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men. Am J Physiol Endocrinol Metab 285: E599-E607, 2003.
51. TAN BK, CHEN J, DIGBY JE, KEAY SD, KENNEDY CR, RANDEVA HS Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia 49: 2723-2728, 2006.
52. TSUCHIDA A, YAMAUCHI T, ITO Y, HADA Y, MAKI T, TAKEKAWA S, KAMON J, KOBAYASHI M, SUZUKI R, HARA K, KUBOTA N, TERAUCHI Y, FROGUEL P, NAKAE J, KASUGA M, ACCILI D, TOBE K, UEKI K, NAGAI R, KADOWAKI T Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279: 30817-30822, 2004.
53. VELDHUIS JD, IRANMANESH A, HO KK, WATERS MJ, JOHNSON ML, LIZARRALDE G Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72: 51-59, 1991.
54. YAMAUCHI T, KAMON J, ITO Y, TSUCHIDA A, YOKOMIZO T, KITA S, SUGIYAMA T, MIYAGISHI M, HARA K, TSUNODA M, MURAKAMI K, OHTEKI T, UCHIDA S, TAKEKAWA S, WAKI H, TSUNO NH, SHIBATA Y, TERAUCHI Y, FROGUEL P, TOBE K, KOYASU S, TAIRA K, KITAMURA T, SHIMIZU T, NAGAI R, KADOWAKI T Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
55. YAMAUCHI T, KAMON J, MINOKOSHI Y, ITO Y, WAKI H, UCHIDA S, YAMASHITA S, NODA M, KITA S, UEKI K, ETO K, AKANUMA Y, FROGUEL P, FOUFELLE F, FERRE P, CARLING D, KIMURA S, NAGAI R, KAHN BB, KADOWAKI T Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
56. YANEY GC, KORCHAK HM, CORKEY BE Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 141: 1989-1998, 2000.
57. YANG L, LIN HK, ALTUWAIJRI S, XIE S, WANG L, CHANG C APPL suppresses androgen receptor transactivation via potentiating Akt activity. J Biol Chem 278: 16820-16827, 2003.
58. ZHOU G, MYERS R, LI Y, CHEN Y, SHEN X, FENYK-MELODY J, WU M, VENTRE J, DOEBBER T, FUJII N, MUSI N, HIRSHMAN MF, GOODYEAR LJ, MOLLER DE Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.